Financials
Financial year 2025
Pathology In Motion from Bocholt, company number BE0685408235, closed financial year 2025 with a result of € 2,068 after tax. For that financial year Pathology In Motion recorded a gross margin of € 3,954 and equity of € 6,651. Compared with financial year 2024, the result moved from € 593 to € 2,068. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.
€ 6,651
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,068
▲ 249% vs 2024
Profit after tax over the fiscal year.
€ 8,493
▼ 57% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 6,651.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 53,840
▼ 33% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,899 | € 2,235 | € 2,202 | € 3,954 | ▲ 80% |
| Profit after taxes | € 130 | € 374 | € 593 | € 2,068 | ▲ 249% |
| Equity | € 22,173 | € 3,991 | € 4,584 | € 6,651 | ▲ 45% |
| Total debts | € 41,865 | € 66,528 | € 80,279 | € 53,840 | ▼ 33% |
| Cash | € 42,578 | € 39,436 | € 19,894 | € 8,493 | ▼ 57% |
| Retained profit | € 3,621 | € 3,991 | € 4,584 | € 6,651 | ▲ 45% |
| Dividend | € 0 | € 4 | € 0 | € 0 | |
| Balance sheet total | € 64,038 | € 70,519 | € 84,863 | € 60,491 | ▼ 29% |
Key figures of Pathology In Motion, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pathology In Motion?
What happened at Pathology In Motion in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2,068 (▲ 249% vs 2024). Source: NBB ↗
- Thomas, Eddy Cleenewerck became a director. NBB
- Inceptive BV stepped down as director. NBB
- New establishment in Bocholt. KBO
- Kris Cardinaels became a director. NBB
- Jan Jozef Maria Verboven became a director. NBB
- Inceptive BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 130 profit in 2022 to € 2,068 profit in 2025.
Paid € 1,896 in corporate taxes since 2022.
Best year ever: 2025, with € 2,068 profit.
Paid out € 4 in dividends to the owners in total.
A new publication or filing at Pathology In Motion? We notify you, reason included.
Follow Pathology In MotionDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pathology In Motion are Kris Cardinaels, Jan Jozef Maria Verboven and Thomas, Eddy Cleenewerck. Kris Cardinaels is also behind krisc-informatica. Thomas, Eddy Cleenewerck is also behind Thomas Cleenewerck.
Directors
According to the 2025 annual accounts
since 2017
Jan Jozef Maria Verboven
Director
since 2017
since 2025
Director · represented by Thomas, Eddy Cleenewerck
since 2017 · until 2025
Establishments
Establishment units
Physical locations of this company
Kloterstraat 12
3950 Bocholt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0685.408.235
- VAT number
- BE 0685.408.235
- Registered office
- Kloterstraat 12, 3950 Bocholt
- Names & denominations
- Pathology In Motion
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 November 2017
- Peppol
- Active · Active since 9 Mar 2026
- Activities · NACE
Overige diensten op het gebied van informatietechnologie en computer
Activiteiten van holdings
Ontwerpen van computerprogramma’s
Overige zakelijke dienstverlening, neg
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten
Holdings
Ontwerpen en programmeren van computerprogramma's